GMV 0.00% 3.9¢ g medical innovations holdings limited

Hydroxychloroquine trial was stopped because an academic...

  1. 1,138 Posts.
    lightbulb Created with Sketch. 208
    Hydroxychloroquine trial was stopped because an academic published a paper stating hydroxychloroquine could lead to more deaths. That was considered bad news for GMV because I thought the emergency approval for GMV product was linked to Hydroxychloroquine . However, the journal has withdrawn the paper because he cannot verify the accuracy of the results. Global trials of hydroxychloroquine will recommence. This must be a very good news for GMV. That is how I read it.
 
watchlist Created with Sketch. Add GMV (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.